Mastrapasqua Asset Management’s Core Laboratories CLB Stock Holding History

Mastrapasqua Asset Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-8,880	Closed	-$1.12M	–	135
2018 Q2	$1.12M	Buy	8,880 +315	+4%	+$38.3K	0.22%	90
2018 Q1	$927K	Buy	+8,565	New	+$948K	0.19%	101

Other funds holding CLB

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Royal London Asset Management United Kingdom $47.7B AUM 29.41% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Mastrapasqua Asset Management's CLB Position: Q3 2018 in Review

Mastrapasqua Asset Management sold out of Core Laboratories (CLB) in Q3 2018, closing a stake of 8,880 shares — an estimated $1.12M sold.

Mastrapasqua Asset Management first reported a position in CLB in Q1 2018 and held it in 2 quarters. The position peaked at $1.12M in Q2 2018. 360 funds tracked by Wall St. Rank hold CLB as of Q3 2018.

Mastrapasqua Asset Management reported no remaining Core Laboratories position as of Q3 2018 after selling out during the quarter.
Mastrapasqua Asset Management sold 8,880 Core Laboratories shares in Q3 2018, an estimated $1.12M.
Mastrapasqua Asset Management first reported a position in Core Laboratories in Q1 2018 and held it in 2 quarters.
Mastrapasqua Asset Management's Core Laboratories position peaked at $1.12M in Q2 2018.
360 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2018.

Based on Mastrapasqua Asset Management's 13F filing for Q3 2018, filed 15 Nov 2018.